Researchers seek participants for mental health services survey

/About-Us/MSF-News-Articles/2308.aspx?lang=en-US 26/02/2021 11:30:33 a. m.

MS more prevalent in Black Americans than previously thought

/About-Us/MSF-News-Articles/2023/2398.aspx?lang=en-US 06/06/2023 10:47:08 a. m.

Study identifies mechanisms for selective MS treatment strategy

/About-Us/MSF-News-Articles/2024/2462.aspx?lang=en-US 07/06/2024 10:43:07 a. m.

Five Tips For Managing Anxiety With MS

/Magazine/Magazine-Items/Exclusive-Content/2019/Five-tips-for-managing-anxiety-with-MS.aspx?lang=en-US 11/11/2019 11:22:18 a. m.

Phase 1 study suggests possible new treatment for MS

/About-Us/MSF-News-Articles/48.aspx?lang=en-US 26/04/2017 09:56:01 a. m.

Rituximab and ocrelizumab both prove effective against disability

/About-Us/MSF-News-Articles/2023/2401.aspx?lang=en-US 13/06/2023 10:46:32 a. m.

Study suggests possible milk allergy, MS link

/About-Us/MSF-News-Articles/2022/2346.aspx?lang=en-US 23/03/2022 11:10:02 a. m.

Study shows potential of subcutaneous injection Ocrevus as treatment option for relapsing, progressi

/About-Us/MSF-News-Articles/2024/2457.aspx?lang=en-US 23/04/2024 10:47:54 a. m.

Study suggests BTK inhibitor slows MS disability progression as effectively as Ocrevus

/About-Us/MSF-News-Articles/2025/2534.aspx?lang=en-US 12/11/2025 10:42:38 a. m.